ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB302

Epstein-Barr Virus-Driven Lymphoproliferative Disorder: Renal Sequelae of a Viral Oncogenic Storm

Session Information

Category: Onconephrology

  • 1700 Onconephrology

Authors

  • Rohrer, Alex, Northeast Ohio Medical University, Rootstown, Ohio, United States
  • Gaur, Mragank, University of Cincinnati, Cincinnati, Ohio, United States
  • Gudsoorkar, Prakash Shashikant, University of Cincinnati, Cincinnati, Ohio, United States
Introduction

Epstein–Barr virus (EBV) infects >95 % of humans, remaining latent (IgG +) and typically silent. EBV-driven lymphoproliferative disease (LPD) can injure kidneys; we report an elderly man with EBV viremia–linked AKI.

Case Description

77-year-old male (diabetes & hypertension) presented with 2 weeks of weight loss, fever, and morbilliform rash for 2 days. Labs (table 1): leukocytosis with atypical lymphocytes, and AKI needing hemodialysis (3 sessions). Immunological workup showed clonal B cell population on flow cytometry. Protein electrophoresis showed 2 M-spikes (IgM kappa, 0.7 g/dL, and IgG lambda, 1.0 g/dL). Infectious workup: marked EBV viremia with negative monospot test and serologies. Positron Emission Tomography (PET)-CT: multifocal FDG-avid uptake in lymph nodes, marrow, and splenomegaly concerning for LPD. Kidney biopsy (Fig 1&2): acute tubulointerstitial nephritis with EBV in situ hybridization stain (ISH) positive in scattered lymphocytes in the interstitium. Liver biopsy: atypical sinusoidal T cell proliferation with scattered B cells showing EBV-encoded small RNAs (EBER) positivity on ISH. BM biopsy: atypical T-cell proliferation, increased EBER-positive B-cells, and focal hemophagocytic activity (no systemic HLH) . Next-generation sequencing showed T-cell receptor gamma gene rearrangement. A diagnosis of Peripheral T cell lymphoma, NOS, involving liver and BM was made and treated with 4 cycles of CHOP (cyclophosphamide, Hydroxydaunorubicin, Vincristine, Prednisone). At ten months, his kidney & liver function & hematology labs are stable (table 1) with no evidence of lymphoma.

Discussion

Multi-organ EBV-LPD is hard to diagnose and treat, requiring thorough pathology to rule out other lymphoid neoplasms. While systemic EBV-related T-cell lymphoma with HLH usually carries a grim prognosis, our patient responded well.

Digital Object Identifier (DOI)